As far as population variability is concerned, the inter-individual differences in human populations with respect to mitochondrial genetic variation, baseline metabolism, inflammatory burden, and compensatory capacity may be significant factors in determining if a particular mitochondrial-targeted therapy restores the adaptive balance or exacerbates dysfunction in an individual patient.
1
—
—